Armata Pharmaceuticals, Inc. Common Stock (ARMP)

Total Costs & Expenses

$44.00M

TTM · Period ending: · USD

ARMP logo

ARMP Total Costs & Expenses

Latest reported$44.00M
ARMP TTM Total Costs & Expenses (-$5.50M → $44.00M)
High-resolution chart · PNG

ARMP total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Armata Pharmaceuticals, Inc. Common Stock Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
43,995,000
40,186,000
39,294,000
37,245,000
42,198,000
45,099,000
47,611,000
46,944,000
45,776,000
44,471,000
45,419,000
45,691,000
44,091,000
44,585,000
42,454,000
38,112,000
35,545,000
31,806,000
28,296,000
28,216,000
26,733,000
23,990,000
22,410,000
19,166,000
20,032,000
20,569,000
19,254,000
20,321,000
15,181,000
13,075,000
12,524,000
10,129,000
9,276,000
10,138,000
10,471,000
10,425,000
13,077,000
12,855,000
14,091,000
14,820,000
13,955,000
12,957,000
10,702,000
10,579,000
13,342,000
14,675,000
14,944,000
17,179,000
14,183,000
16,594,000
15,311,000
12,998,000
13,587,000
10,964,000
14,378,000
16,004,000
19,184,000
21,406,000
25,053,000
26,311,000
27,491,000
56,702,000
54,119,000
53,591,000
75,641,000
45,551,000
45,378,000
46,298,000
23,429,000
24,695,000
24,435,000
24,417,000
24,843,000
24,601,000
26,801,000
26,130,000
27,900,000
27,877,000
30,558,000
34,437,000
36,637,000
42,074,000
47,858,000
32,179,000
30,912,000
29,254,000
23,665,000
35,786,000
31,819,000
26,706,000
18,230,000
17,055,000
15,625,000
14,800,000
18,300,000
17,300,000
16,400,000
16,400,000
15,100,000
15,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.